Dr. Amit Mahipal, MD
Claim this profileMayo Clinic
About Amit Mahipal, MD
Education:
Obtained MD from Maulana Azad Medical College, India, in 2003.
Completed Residency in Internal Medicine at the University of Connecticut Health Center (2005-2008).
Undertook Fellowship in Hematology/Oncology at Thomas Jefferson University Hospital (2008-2011).
Experience:
Specializes in Hematology and Oncology.
Affiliated with University Hospitals in Cleveland and Beachwood, Ohio.
Certified by the American Board of Internal Medicine in Hematology and Medical Oncology.
Area of expertise
Bile Duct Cancer
Amit Mahipal, MD has run 8 trials for Bile Duct Cancer. Some of their research focus areas include:
Cancer
Amit Mahipal, MD has run 5 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Hospitals Cleveland Medical Center
Mayo Clinic Rochester
Clinical Trials Amit Mahipal, MD is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting
1 award
Phase 2
3 criteria
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting
2 awards
Phase 3
More about Amit Mahipal, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Amit Mahipal, MD has experience with
- Cisplatin
- Gemcitabine
- ELU001
- Fulvestrant
- Tucatinib
- Trastuzumab
Breakdown of trials Amit Mahipal, MD has run
Bile Duct Cancer
Cancer
Pancreatic Cancer
Liver Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Mahipal, MD specialize in?
Amit Mahipal, MD focuses on Bile Duct Cancer and Cancer. In particular, much of their work with Bile Duct Cancer has involved Stage IV patients, or patients who are FGFR2 positive.
Is Amit Mahipal, MD currently recruiting for clinical trials?
Yes, Amit Mahipal, MD is currently recruiting for 3 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Amit Mahipal, MD has studied deeply?
Yes, Amit Mahipal, MD has studied treatments such as Cisplatin, Gemcitabine, ELU001.
What is the best way to schedule an appointment with Amit Mahipal, MD?
Apply for one of the trials that Amit Mahipal, MD is conducting.
What is the office address of Amit Mahipal, MD?
The office of Amit Mahipal, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.